text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 635702-64-6 | Product Number: P2243

Pazopanib Hydrochloride


Purity: >95.0%(T)(HPLC)
Synonyms:
  • 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide Hydrochloride
Product Documents:
50MG
₹4,000.00
Contact Us ≥40 
250MG
₹14,000.00
Contact Us 12  

*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.


Product Number P2243
Purity / Analysis Method >95.0%(T)(HPLC)
Molecular Formula / Molecular Weight C__2__1H__2__3N__7O__2S·HCl = 473.98 
Physical State (20 deg.C) Solid
Storage Temperature Frozen (-20°C)
Store Under Inert Gas Store under inert gas
Condition to Avoid Air Sensitive,Hygroscopic,Heat Sensitive
CAS RN 635702-64-6
PubChem Substance ID 468592583
MDL Number

MFCD12546138

Specifications
Appearance White to Almost white powder to crystal
Purity(HPLC) min. 95.0 area%
Purity(Nonaqueous Titration) min. 95.0 %
Water max. 3.0 %
Properties (reference)
GHS
Pictogram Pictogram
Signal Word Warning
Hazard Statements H361 : Suspected of damaging fertility or the unborn child.
Precautionary Statements P501 : Dispose of contents/ container to an approved waste disposal plant.
P202 : Do not handle until all safety precautions have been read and understood.
P201 : Obtain special instructions before use.
P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection.
P308 + P313 : IF exposed or concerned: Get medical advice/ attention.
P405 : Store locked up.
Related Laws:
Transport Information:
Application
Pazopanib Hydrochloride: An Oral Small Molecule Multi-Tyrosine Kinase Inhibitor

Pazopanib hydrochloride (GW786034B) is an oral small molecule multi-tyrosine kinase inhibitor. It has been demonstrated that pazopanib shows inhibitory action for vascular endothelial growth factor receptor (VEGFR)-1, VEGFR-2, VEGFR-3, platelet-derived growth factor receptor (PDGFR)-α and β, fibroblast growth factor receptor (FGFR)-1 and -3, cytokine receptor (Kit), interleukin-2 receptor-inducible T-cell kinase (Itk), lymphocyte-specific protein-tyrosine kinase (Lck), and transmembrane glycoprotein receptor tyrosine kinase (c- Fms). Pazopanib is thought to inhibit tumor growth by inhibiting the activation of VEGFR and PDGFR related to angiogenesis, which is involved in tumor growth. (The product is for research purpose only.)

References


Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

Specifications
C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The product with the lot number searched for has been discontinued and no related documentation is available.

Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.

A sample C of A for this product is not available at this time.

Analytical Charts
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The requested analytical chart is not available. Sorry for the inconvenience.

The product with the lot number searched for has been discontinued and no related documentation is available.

Other Documents

Life Science
Session Status
Your session will timeout in 10 minutes. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page. minute. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page.

Your session has timed out. You will be redirected to the HOME page.

TCI
Please enter the required fields (*)
Please enter valid mobile number
New User? *
Add me to your mailing list *

Thank you for signing up!


New subscribers will get FREE TCI Gifts!
We will notify you of further updates on our New products, Offers, Schemes, Discounts, etc.


OK